NCT03927287View on ClinicalTrials.gov

Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

822

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 30, 2018

Study Completion Date

April 10, 2019

Conditions
MetastasisCastration-resistant Prostate CancerDeath
Interventions
DIAGNOSTIC_TEST

Free PSA ratio test in patients after definitive treatment for localized prostate cancer

Free PSA ratio blood test done on biobank samples of patients after radical prostatectomy who developed biochemical recurrence.

Trial Locations (1)

M5G2M9

Princess Margaret Cancer Center, Toronto

All Listed Sponsors
collaborator

University of Toronto

OTHER

lead

Rabin Medical Center

OTHER

NCT03927287 - Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer | Biotech Hunter | Biotech Hunter